Crystalloid vs Colloid: Evidence-Based Fluid Selection in Veterinary Emergency

Isotonic crystalloids remain the first-line resuscitation fluid in veterinary emergency medicine. The three most commonly used isotonic crystalloids are Lactated Ringer's Solution (LRS), 0.9% Sodium Chloride (Normal Saline), and Plasmalyte-A/Normosol-R. These balanced electrolyte solutions have osmolalities close to plasma (270-310 mOsm/L) and distribute freely across the extracellular fluid compartment.

LRS is the most widely used veterinary resuscitation fluid. Its composition approximates extracellular fluid, containing sodium (130 mEq/L), potassium (4 mEq/L), calcium (3 mEq/L), chloride (109 mEq/L), and lactate (28 mEq/L) as a buffer. The lactate is metabolized hepatically to bicarbonate, providing mild alkalinizing effect. LRS is appropriate for most hypovolemic patients but should be avoided in patients with hypercalcemia or severe hepatic failure where lactate metabolism is impaired.

Normal saline (0.9% NaCl) contains only sodium (154 mEq/L) and chloride (154 mEq/L). Its supraphysiologic chloride concentration can cause hyperchloremic metabolic acidosis with large-volume resuscitation. However, it remains the fluid of choice for patients with hyperkalemia, hypercalcemia, or those receiving blood products, since it contains no calcium to cause citrate chelation.

7.5% Hypertonic saline (HTS) is a potent osmotic agent used for rapid, small-volume resuscitation. At a dose of 3-5 mL/kg IV over 5-10 minutes, HTS draws interstitial and intracellular water into the vasculature, expanding plasma volume by 3-5 times the infused volume. This makes it invaluable for initial resuscitation of large dogs where rapid administration of large crystalloid volumes is logistically challenging.

HTS also reduces intracranial pressure, making it beneficial in traumatic brain injury patients. However, its effects are transient (lasting approximately 30-60 minutes), and it must be followed by isotonic crystalloid or colloid infusion. HTS is contraindicated in dehydrated patients, as there is insufficient interstitial fluid to mobilize. It should also be avoided in hypernatremic patients.

Natural colloids include fresh frozen plasma (FFP), frozen plasma, and concentrated albumin solutions. FFP contains all coagulation factors, albumin, antithrombin, and immunoglobulins. It is indicated for coagulopathy (rodenticide toxicity, DIC), hypoalbuminemia with oncotic pressure loss, and as a source of antithrombin in sepsis.

Canine and feline albumin solutions (lyophilized or concentrated) provide targeted oncotic support. Human serum albumin (HSA) has been used in veterinary medicine but carries risk of type III hypersensitivity reactions, particularly with repeated administration. Species-specific albumin is preferred when available. The oncotic threshold for clinical edema formation is typically an albumin level below 1.5 g/dL.

Hydroxyethyl starch (HES) solutions, including Hetastarch (6% HES 450/0.7) and Vetstarch (6% HES 130/0.4), are synthetic glucose polymers that provide sustained intravascular volume expansion. A dose of 5-20 mL/kg in dogs (5-10 mL/kg in cats) expands plasma volume approximately 1:1 with infused volume, and effects last 12-24 hours depending on the molecular weight and degree of substitution.

The controversy surrounding synthetic colloids stems from human critical care literature. The 2012 CHEST and 6S trials demonstrated increased risk of acute kidney injury (AKI) and mortality in human sepsis patients receiving HES. While direct extrapolation to veterinary patients is debated, several retrospective veterinary studies have also suggested associations between HES use and AKI, particularly in cats and in patients with pre-existing renal compromise.

The decision between crystalloid and colloid is not binary but rather a stepwise escalation based on patient response. Begin with isotonic crystalloid boluses (dogs: 10-20 mL/kg; cats: 5-10 mL/kg) and reassess perfusion parameters after each bolus. If the patient has received a full shock dose of crystalloids (dogs: 60-90 mL/kg; cats: 40-60 mL/kg) without adequate response, consider adding a colloid.

Specific indications for colloids include: albumin <1.5 g/dL with peripheral edema or third-spacing, persistent hypotension despite crystalloid resuscitation, need to limit total fluid volume (cardiac patients), and coagulopathy (FFP specifically). The Triage/Emergency Specialist can help guide fluid selection for complex cases.

The 2024 AAHA fluid therapy guidelines emphasize individualized, goal-directed fluid therapy over protocolized volume loading. Key recommendations include: use balanced crystalloids (LRS or Plasmalyte) as first-line, titrate boluses to effect rather than administering full calculated shock doses empirically, monitor lactate clearance as a resuscitation endpoint, and reserve synthetic colloids for patients who fail crystalloid resuscitation with documented hypoalbuminemia or oncotic pressure loss.

The COVE (COnsensus on VEterinary colloid use) guidelines similarly recommend restricting synthetic colloid use to cases where the benefit-to-risk ratio is clearly favorable, avoiding HES in patients with sepsis, renal disease, or coagulopathy.